may 20, 2013 monday memo health reform update · 2013. 5. 20. · deloitte center for health...
Post on 23-Aug-2020
0 Views
Preview:
TRANSCRIPT
Deloitte Center for Health Solutions
May 20, 2013
Monday memo
Health reform update
This week’s headlines: My take
Implementation update - CBO updates ACA impact on coverage, costs - CMS seeks Bundled Payments applicants - New funds for innovation available - 4th Circuit hears ACA challenge - PCIP guidance released as program winds down - CMS proposed rule would separate DSH payments from Medicaid expansion
temporarily - IRS, HHS release MLR guidance for certain organizations, Medicare Part C and Part D
plans
Legislative update - Physician ban on hospital ownership challenged - Tavenner confirmed - House passes legislation to repeal ACA for 37th time - Report: increases in premium prices due to ACA - Track and trace legislation advances in Congress with bipartisan support - Health care related legislation introduced last week
State update - State round-up: HIX
- Medicaid expansion update
- State round-up
Industry news - AMA membership up, revenues down - Stem cell cloning promising as Oregon researchers - SEC investigating political intelligence activity - Jolie preventive mastectomy puts spotlight on genetic testing for cancer risk - IOM: salt intake precautions not warranted; American Heart Association disagrees - Immunotherapy market might be $20 billion annually
Research snapshots
Quotable
Fact file
Subscribe to the Health Care Reform Memo
Deloitte Center for Health Solutions research
Read the blog
Upcoming life sciences and health care Dbriefs webcasts
Deloitte contacts
My take
From Paul Keckley, Executive Director, Deloitte Center for Health Solutions
As student body president in college, I had occasion to meet Governor Buford Ellington in
the Tennessee State House on numerous occasions. I was star-struck. The idea of being
governor fascinated me, so much so that a few years later I asked our young governor,
Lamar Alexander, how I might be his successor one day. His counsel was wise: it’s not a
career for the timid or those who can’t handle controversy and criticism. But it’s the role in
government closest to the people governed. A governor’s decision isn’t one among 99
others in the Senate or 434 in the House. It’s a huge role, and health care oversight is a
major part of the job. It’s understandable.
According to the National Conference of State Legislators, in the average state, health
care is 28-35% of the budget. States have authority over the Medicaid, Children’s Health
Insurance Plan (CHIP), and state employee benefits. States determine scope of practice
and licensing authority for providers, manage homeland security, including emergency
preparedness, regulate health insurance operators, distribute disproportionate share
(DSH) hospital payments, oversee school and correction facilities’ health programs, and
operate a network of clinics and human services programs that are a lifeline to the most
disadvantaged in the state. Now add the unique requirements of the Affordable Care Act
(ACA): development and management of their state health insurance exchanges (HIX)
and the possible expansion of their Medicaid programs are high on every governor’s
agenda these days. All these require deliberate analysis and calculated risk, not to
mention, managing relationships (and votes) within state legislative bodies.
Last week, I spoke on the topic of health care at the Republican Governors Association in
New Orleans and had one-on-one discussions with several members in the course of the
two day event. In the recent past, I’ve had similar conversations with several Democratic
governors, but my answers to their questions are the same regardless of their party
affiliation. Governors across the country are asking good questions…
They ask about the ACA: how is implementation going and when will pending
rules and guidance be available so states know what to do next? And among the
mostly GOP chief executives who have defaulted to the federally-facilitated option:
is the federal government prepared to help states with their HIXs this fall?
They ask about Medicaid: what are the best practices for managing the health in
this population in a cost effective way? They wonder how to connect public health
programs serving the poor with health care systems and practitioners who serve
those with insurance.
They ask about state employee health plans: how can state employees’ benefits
more closely mirror private sector plans through defined contribution plans and
narrow networks?
They ask about the private sector: how are hospitals, doctors, commercial health
insurers, and long-term care providers adapting to pressures about waste, fraud,
and transparency?
They wonder about the health care workforce and jobs in their state: is the
system adequate, or is re-training of workers from clinicians to hourly employees
necessary to a new system of care? Where are their opportunities to lead in
attracting new jobs and new talent to an industry that’s one-sixth of the overall
national gross domestic product (GDP)?
And they ask about public awareness: does the public understand the health
care system, or the ACA, or for that matter their own insurance and the providers
they use? And why is public opinion about health reform so divisive and views
strongly held on every side of every issue?
This week I will follow-up with several governors who asked to discuss specific matters in
more detail. But reflecting on last week, I can’t help but recall those discussions with
Governor Alexander and my early impressions of Governor Ellington from my college
days. Being governor is a tough job, regardless of political affiliation. And knowing how to
navigate the health care system, or lead in its needed reforms, are monumental
challenges likely to keep many governors awake at night these days.
return to top
Implementation update
CBO updates ACA impact on coverage, costs Last week, the Congressional Budget Office (CBO) released its latest forecast of
anticipated expanded health insurance coverage and costs associated with ACA
implementation compared to its forecast in February 2013.
Highlights:
Medicare: net mandatory spending from 2014-2023 is expected to be $7.9 trillion—
$85 billion lower than projected in February 2013—due to “a reduction of $143
billion in projected gross spending for benefits, partially offset by reductions of $48
billion in collections of offsetting receipts and $10 billion in Medicare savings as a
result of sequestration.”
Sustainable Growth Rate (SGR): repeal is projected to cost $139.1 billion vs. the
February 2013 projection of $138.3 billion.
Medicaid: spending from 2014-2023 is projected to be $4.3 trillion, which is 2%
lower than February 2013 estimates.
Coverage: of the newly eligible Medicaid population, 20% will be living in states that
will not expand, 70% will be living in states that opt to expand, and 10% will be living
in states that partially extend Medicaid eligibility criteria.
Net changes (millions):
February 2013 Baseline May 2013 Baseline Difference
Medicaid and CHIP 12 13 1
Employment-based -7 -7 -
Non-group and
other -4 -5 -1
HIX 25 24 -1
Uninsured -27 -25 1
Source: CBO; staff of the Joint Committee on Taxation,
http://www.cbo.gov/publication/44176
ACA revenues: “CBO and [Joint Committee on Taxation (JCT)] reduced the
estimated amount of penalty payments by employers by $10 billion over the 2014-
2023 period. That revision stems from the slight increase in projected employment-
based coverage and a regulatory change that reduces the extent of employers’
liability for penalties.” Employer tax on high-cost health plans (known as the Cadillac
Tax) is projected to yield $58 billion over ten years.
ACA impact on the federal deficit, fiscal years (FY) 2013-2023 (in billions):
ACA Provisions Feb. 2013 baseline May 2013 baseline Difference
Medicaid and CHIP outlays $637 $710 $74
HIX subsidies $1,212 $1,075 $(137)
Small-employer tax credits $24 $14 $(10)
Gross cost of provisions $1,872 $1,798 $(74)
Penalty payments by
uninsured individuals $(52) $(45) $7
Penalty payments by
employers $(150) $(140) $10
Excise tax on high
premium insurance plans $(137) $(80) $58
Other effects on tax
revenues and outlays $(210) $(171) $39
Net cost of coverage provisions
$1,323 $1,363 $40
Source: CBO; staff of the Joint Committee on Taxation,
http://www.cbo.gov/publication/44176
My take: since passage of the ACA in March 2010, the CBO and JCT have released six
baseline updates on costs and anticipated revenues. Per the chart below, all show
dramatic increases in deficit impact from 2013 to 2016, leveling out in the last half of the
decade and beyond to a net deficit impact of at least $150 billion annually for the
foreseeable future.
So here’s the bottom line: health care spending will likely continue to add to the overall
deficit of the U.S. unless one of two things happen: 1) government and private payers
simply pay less to providers or 2) providers charge less. Still, it does not alter dramatically
the underlying math: health care spending is a matter of volume x price. If efforts in the
ACA and private sector simply adjust what’s paid (prices) without addressing volume
(utilization), deficits associated with health care spending will continue to play a greater
role in the federal spending gap between revenues and expenses.
The ACA includes some provisions that try to address volume: it poses demonstrations
and pilots involving medical homes, bundled payments, and accountable care to
incentivize providers to coordinate care better. But it falls short in accelerating the
transition from volume to value. In the next wave of health care reform legislation,
attention should be given to reduced volume. Otherwise, costs will continue to exceed
government revenues and deficits will soar.
The alternative of doing nothing seems lacking in any sense of fiscal realism as, prior to
the ACA, health care costs increased for a decade at 5.9% annually. The ACA may
reduce the long-term deficit somewhat, but even its strongest proponents acknowledge it
alone is inadequate to tackle systemic cost spiraling in health care. I continue to think the
solution to long-term systemic cost controls are three: 1) replacing fee-for-service
incentives with performance-based payments, 2) paying only for what the evidence says
works, and 3) equipping consumers with a full set of tools to know their treatment options,
costs, which provider teams deliver the highest value, and which insurance they think
appropriate to their own circumstance.
CBO’s estimates of Net Budgetary Impact of the Coverage Provisions Contained in
the ACA 2010-2013
Source: CBO; staff of the Joint Committee on Taxation, http://www.cbo.gov/publication/44176
return to top
CMS seeks Bundled Payments applicants CMS is recruiting acute hospitals to apply for participation in Model 1 (inpatient services)
of the Bundled Payments for Care Improvement initiative that began last month (Section
3021 of the ACA). Applications will be accepted until July 31, 2013. Currently, 24 health
care facilities in New Jersey are participating in this initiative.
return to top
New funds for innovation available Last week, CMS announced $1 billion in Health Care Innovation Awards for projects to
test new payment and service delivery models for enrollees in Medicare, Medicaid, and
CHIP. Letters of intent will be accepted through June 28, 2013. In 2012, 107 organizations
received funding out of the 3,000 organizations that applied.
return to top
4th Circuit hears ACA challenge Last week, the 4th Circuit Court heard Liberty University’s arguments against the ACA’s
employer mandate requirement as a Constitutional violation under the Commerce Clause.
return to top
PCIP guidance released as program winds down Last week, the U.S. Department of Health and Human Services (HHS) issued an interim
final rule setting most reimbursement rates in federally-administered Pre-existing
Condition Insurance Plan (PCIP) programs at Medicare levels. The rule also bans
“balance billing” enrollees of the federally-run PCIPs to protect them “from having to
potentially shoulder significant costs that could be shifted to them as a result of this new
payment policy.”
Related: ten of 27 states running their own high-risk pools per the ACA have announced
they will maintain control of them before the program sunsets at the end of this year.
States were given the option to maintain their PCIP program or transfer oversight to HHS
after the department proposed a new contract that would cap the amount of funds states
could receive to cover enrollees. Seventeen states chose to let HHS administer the
program, fearing future funding shortfalls the states might experience. HHS will administer
the PCIP program 40 states until December 2013.
return to top
CMS proposed rule would separate DSH payments from Medicaid
expansion temporarily Last week, CMS issued proposed regulatory guidance on Medicaid Disproportionate
Share Hospital (DSH) reductions for FY2014 and FY2015 only. Per the ACA, DSH
payments are to be reduced incrementally through 2020, but CMS reasoned that the “two-
year methodology accommodates data refinement and methodology improvement before
larger reductions begin in FY2017.” CMS will not take states’ decisions about Medicaid
expansion into consideration during the initial two years, temporarily shielding states that
have decided to expand Medicaid from potentially steeper DSH cuts due to those states’
future reductions in uninsured levels. Comments will be accepted until July 12, 2013. This
rule will be effective January 1, 2014 unless Congress adopts President Obama’s
proposal to delay DSH reductions.
return to top
IRS, HHS release MLR guidance for certain organizations, Medicare Part C
and Part D plans Last week, the Internal Revenue Service (IRS) issued a proposed rule for certain
organizations on how to compute the medical loss ratio (MLR) requirements to maintain
privilege under Section 833 of the tax code. It proposes that affected plans use the
definition for “reimbursement for clinical services provided to enrollees” for Section 833 to
have the same meaning as under section 2718 of the Public Health Service Act.
However, the proposed regulation does not adopt “activities that improve health care
quality” as part of their 85% minimum threshold for reimbursement for clinical
expenditures. Comments will be accepted until August 12, 2013.
Background: Section 9016 of the ACA “amended section 833 of the [tax] Code, which
provides special rules for the taxation of…certain organizations that provide health
insurance.”
Friday, HHS issued a final rule on MLR for the Medicare Advantage (MA) program (Part
C) and the Medicare Prescription Drug Benefit Program (Part D) to implement Section
1103 of the ACA. The estimated administrative costs related to the MLR reporting
requirements as finalized are $9.6 million in one-time costs and $2.8 million in ongoing
costs across 616 contracts.
Background: the ACA established the MLR to regulate the amount health plans spend on
beneficiaries’ health care costs vs. overhead and administrative costs (i.e. executive
salaries). Health plans must spend 80% or 85% of premium revenues on beneficiaries.
Beginning in 2012, health plans that do not meet these requirements must issue rebates
to health plan participants. For MA and Part D plans, if they fail to meet MLR requirements
for three consecutive years, they will be subject to enrollment sanctions; after five
consecutive years they will be subject to contract termination.
return to top
Legislative update
Physician ban on hospital ownership challenged Section 6001 of the ACA bans the start of new physician-owned hospitals (POHs) and
limits existing ones from expanding. When passed in 2010, there were 265 POHs; today
there are 238. In addition, plans for 24 POHs were suspended.
Last week, representatives of Physician Hospitals of America (PHA) were on the Hill
asking that Section 6001 of the ACA be repealed. Their claim: POHs provide better care
than competing acute facilitates according to data from the December 2012 U.S. Centers
for Medicare & Medicaid Services (CMS). According to the data, of 3,000 hospitals, POHs
were nine of the top ten and 48 of the top 100 that received a 1% Medicare bonus through
CMS’ hospital value-based purchasing program.
Opponents including the American Hospital Association, Federation of American
Hospitals, and others counter that POHs encourage unnecessary procedures and cherry-
picking of commercially insured patients, and point to data from the American Hospital
Directory, an independent financial database covering 6,000 hospitals, that showed profits
in POHs ranging from 20-35% versus 7% for non-physician-owned.
(Source: Wall Street Journal, “Doc-Owned Hospitals Prep to Fight,” May 13, 2013)
My take: the bigger issues in this debate are two: 1) does a physician have the right to
determine which patients he/she will treat, and 2) is the greater good served when
physician self-referral is limited? Both need public debate, and those on both sides of the
debate should be transparent in providing data about profit-sharing arrangements with
physicians, appropriateness of care, and quality. The issue is not just about POHs. It’s
about the larger issue of transparency and the role and scope of legislative oversight of a
profession.
return to top
Tavenner confirmed Marilyn Tavenner was confirmed Wednesday as the first permanent CMS administrator
since 2006. The 91-7 vote followed unanimous endorsement by the Senate Finance
Committee co-Chairs, Orrin Hatch (R-UT) and Max Baucus (D-MT). Tavenner has served
as acting administrator since late 2011, when Dr. Donald Berwick stepped down.
return to top
House passes legislation to repeal ACA for 37th time Friday, the U.S. House of Representatives passed legislation to repeal the ACA (229-
195). The vote was along party lines, with the exception of two Democrats, voting in favor
of repeal: Representative Jim Matheson (D-UT) and Mike McIntyre (D-NC).
Note: the CBO estimates full repeal would increase federal budget deficits by $109 billion
over ten years.
return to top
Report: increases in premium prices due to ACA Last week, the U.S. House of Representatives Energy and Commerce Committee
released a report on health insurance rates for plan year 2014 based on data provided by
insurance companies.
Findings:
Individual market: on average, new plans may cost 96% more and existing non-
grandfathered plans may cost 73% more; average yearly cost may increase $1,812
for new customers.
Small group market: 50% rate increases.
Large group market: 15 to 20% rate increases.
(Source: U.S. House of Representatives, Committee on Energy and Commerce, “The
Looming Premium Rate Shock,” May 13, 2013)
Note: average increases may be offset by subsidies available for individuals and
companies with fewer than 10 employees purchasing coverage on HIXs beginning in
2014.
return to top
Track and trace legislation advances in Congress with bipartisan support A bill (S. 957) to implement an interoperable, electronic, unit-level tracing system
throughout the drug supply chain (i.e. track and trace) is expected to be marked up by the
Senate this week. Last week, the House passed a similar bill (H.R. 1919) by voice vote.
Differences:
S. 957 transitions to a unit-level system over a ten-year period; H.R. 1919 would not
require a unit-level system until 2027.
S. 957 would require supply chain entities to pass and retain transaction history
information for each drug product for seven years vs. three years proposed by H.R.
1919.
return to top
Health care related legislation introduced last week
Senator Al Franken (D-MN) introduced legislation (S. 935) proposing to prohibit the
Secretary of Veterans Affairs from requesting additional veteran medical
examinations when sufficient medical records are already provided by non-
department medical professionals.
Senator Roy Blunt (R-MO) introduced legislation (S. 931) intended to raise
awareness among breast cancer patients about the availability and coverage of
breast reconstruction, prostheses, and other coverage options.
Representative Chellie Pingree (D-ME) introduced legislation (H.R. 1976) proposing
to provide women enrolled in Medicaid access to certified professional midwives.
Representative John Kline (R-MN) introduced legislation (H.R. 1971) proposing to
provide certain TRICARE beneficiaries with the opportunity to retain access to
TRICARE Prime.
Representative Elijah Cummings (D-MD) introduced legislation (H.R. 1958)
proposing to prohibit wholesalers from purchasing drugs from pharmacies, and to
enhance information and transparency regarding drug wholesalers engaged in
interstate commerce.
Senator Charles Schumer (D-NY) introduced legislation (S. 948) proposing to
provide coverage and payment for complex rehabilitation technology items under
Medicare.
Senator Jeanne Shaheen (D-NH) introduced legislation (S. 945) proposing to
improve access to diabetes self-management training.
return to top
State update
State round-up: HIX 17 states—13 led by Democratic governors, three led by Republicans, and one
Independent—and the Democratic mayor of D.C. have announced plans to operate state-
based exchanges. Seven states—five led by Democratic governors and two led by
Republicans—will participate in state-partnership exchanges. The remaining 26 states will
default to a federally-facilitated exchange.
State-based exchange State-partnership exchange Federally-facilitated exchange
CA, CO, CT, DC, HI, ID, KY, MA, MD, MN, NM, NV, NY, OR, RI, UT*, VT, WA
AR, DE, IA, IL, NH, MI, WV AK, AL, AZ, FL, GA, IN, LA, KS, ME, MO, MS, MT, NC, ND, NE, NJ, OH, OK, PA, SC, SD, TN, TX, VA, WI, WY
■ Democratic governor ■ Republican governor ■ Independent governor
*Utah’s individual market will be a federally-facilitated Exchange; small business health option program (SHOP) will be a state-based
Source: HHS
Chicago, Illinois will phase out its 55% subsidy for retiree health care plans in 2014
and encourage the retired population to enroll in health plans on the HIX. Nearly
30,000 retired employees are expected to switch to the state-partnership exchange,
which is expected to save the taxpayers $108.7 million in a year.
Washington State will not be ready to launch its small group market HIX for small
employers (i.e. SHOP) by October 2013, but will implement a pilot program in
selected counties in the interim; the state hopes to expand SHOP state-wide next
fall.
California announced that $37 million will be used to educate its residents about
the HIX. The executive director of the state’s HIX stated $34 million of the funds will
target consumers and the remaining $3 million will be used to reach out to small
business.
D.C. anticipates at least four health insurance companies to offer almost 300
different policies on its state-based HIX.
return to top
Medicaid expansion update Medicaid expansion is projected to cost the federal government $952 billion between
2013 and 2022 and states $76 billion. To date, 26 states and D.C. have said they will or
are in support of expanding their Medicaid programs; 20 states have indicated they are
unlikely to expand their programs in 2014:
Announced expansion or likely to expand
Not participating or unlikely to participate
Undecided or undeclared
AR, AZ, CA, CO, CT, DE, DC, HI, IL, KY, MD, MA, MI, MN, MO, ND, NH, NM, NY, NJ, NV, OR, OH, RI, VT, WA, WV
AL, AK, FL, GA, ID, IN, IA, LA, ME, MS, MT, NE, NC, OK, PA, SC, SD, TX, VA, WI
KS, WY, TN, UT
■ Democratic governor ■ Republican governor ■ Independent governor
Sources: JAMA, “Medicaid expansion under the Affordable Care Act,” March 27, 2012; Kaiser Family
Foundation; PoliticoPro, StateReforum
Note: states do not have a deadline to make a decision on Medicaid expansion and may opt in or out of
participation at any time. This chart was compiled using publicly available information (as of May 19, 2013) and
is subject to change.
Findings from a study conducted by George Washington University and Robert
Wood Johnson Foundation found that individuals churning on and off Medicaid in a
calendar year pay $625/month in medical bills, while individuals that remain on
Medicaid for a consecutive 12-month period pay on average $333/month.
Last week, the Michigan Senate approved a budget bill (Bill 198) excluding funds
for Medicaid expansion. Earlier this year, a similar bill was passed in the House.
The legislature must reconcile budget bills within the next two weeks. The House
will hold hearings on legislation this week that, if passed, would allow the state to
expand Medicaid under certain conditions.
Last Thursday, the Arizona Senate passed a budget bill that contained an
amendment aligning with Governor Jan Brewer’s (R-AZ) Medicaid expansion plan
allowing 350,000 people to become eligible for coverage. The bill will move to the
House for a vote where passage is unclear.
return to top
State round-up Last Monday, Vermont legislators approved a bill (75-65) that would permit doctors
to prescribe euthanasia drugs to terminally ill patients. Two other states,
Washington and Oregon, have a similar law.
Background: as of 2011, 935 prescriptions were prescribed since Oregon’s 1998
passage of the law; roughly, two-thirds have been administered.
The Oregon House passed (54-4) a reauthorization of a hospital and nursing home
tax until 2020. This 4.3% tax has generated an estimated $745 million in tax
revenue and $1.3 billion in Medicaid matching funds over the last decade. The bill,
which raises the tax by 1 percentage point, is set to go to the state Senate next
week.
Last week, the Delaware House unanimously passed a bill allowing a free standing
acute rehabilitation hospital to be built without state review; previously required
under state law.
return to top
Industry news
AMA membership up, revenues down Despite a 3.2% increase in membership, the American Medical Association's (AMA)
operating profit dropped by 33% last year due to “a material decline” in advertising
revenue and coding book sales.
Note: membership in AMA is open to practicing physicians ($420/year dues), medical
residents ($45/year dues) and medical students *$20/year dues). Currently, nearly
225,000 (17%) of the nation’s physicians, residents and medical students are members.
(AMA Annual Report, May 16, 2013)
return to top
Stem cell cloning promising as Oregon researchers News last Wednesday that scientists in Oregon Health Sciences University reported
successful harvesting of stem cells from six embryos created from donated eggs. The
research was financed by the university and the Leducq Foundation in Paris.
return to top
SEC investigating political intelligence activity The Securities Exchange Commission (SEC) has opened an investigation into insider
trading involving health insurance industry stocks during the period between March 15
and the April 1 after an announcement by CMS that it would not cut Medicare Advantage
payments as earlier thought. At issue: whether Congressional aides might have relayed
information about the decision before publicly available, which would be a violation of
insider trading rules. If a lobbyist or analyst made a prediction based on publicly available
information, it would be not be a violation. Regulators are also investigating the role of
political intelligence firms that advise commercial clients about pending government
activity to assure no violations of insider trading rules by sources in government.
return to top
Jolie preventive mastectomy puts spotlight on genetic testing for cancer
risk Actress Angelina Jolie’s double mastectomy in February became a major news item last
week after she spoke about it publicly. She made the decision to have the procedure
performed after she tested positive for a mutation in the BRCA1 gene. Each year, 232,000
women are diagnosed with breast cancer and 40,000 die. The National Cancer Institute
says that the two mutations, BRCA1 and BRCA2, account for 10% of breast cancers and
15% of ovarian cancers. But women who have both have a 60% chance of having breast
cancer in their lifetime. A woman choosing double mastectomy reduces her lifetime risk by
90%. The tests for both BRCA mutations are marketed by Myriad Genetics Inc. of Salt
Lake City and are covered by most insurance plans.
return to top
IOM: salt intake precautions not warranted; American Heart Association
disagrees Last week, an expert committee appointed by Institute of Medicine (IOM) for the Centers
for Disease Control and Prevention issued a report challenging directives to limit salt
intake to less than 1,500 milligrams/day—about a half a teaspoon. The group’s report
concluded that 1,500-2,300 milligrams/day or below were appropriate and would not raise
blood pressure. The average sodium consumption in the U.S. is 3,400 milligrams/day.
However, groups including the American Heart Association and Center for Science in the
Public Interest challenged the recommendation based on what they deemed flawed
methodology.
return to top
Immunotherapy market might be $20 billion annually On the eve of the American Society of Clinical Oncology annual meeting in Chicago later
this month, Leerink Swann released analysis that the immuno-oncology drug market could
reach $20 billion annually. The findings were based on promising studies from Bristol
Myers Squibb, Roche Holdings, and Merck.
return to top
Research snapshots New industry and peer-reviewed studies of note to health system transformers…
Recent health spending trend might persist to produce longer-term savings Citation: David Cutler, Mikhil Sahni, “If Slow Rate Of Health Care Spending Growth
Persists, Projections May Be Off By $770 Billion,” Health Affairs, May 2013
Objective: to determine if the recent slower annual growth rate in health spending—3%
per year for 2009-2011 versus 5.9% per year for prior decade is persistent or temporary,
and identify causative factors.
Methodology: analysis of the CMS Office of the Actuary data for 2003 to 2012.
Conclusions: “We find that the 2007–09 recession, a one-time event, accounted for 37
percent of the slowdown between 2003 and 2012. A decline in private insurance coverage
and cuts to some Medicare payment rates accounted for another 8 percent of the
slowdown, leaving 55 percent of the spending slowdown unexplained. We conclude that a
host of fundamental changes—including less rapid development of imaging technology
and new pharmaceuticals, increased patient cost sharing, and greater provider
efficiency—were responsible for the majority of the slowdown in spending growth. If these
trends continue during 2013–22, public-sector health care spending will be as much as
$770 billion less than predicted. Such lower levels of spending would have an enormous
impact on the US economy and on government and household finances.”
(Source: David Cutler, Mikhil Sahni, “If Slow Rate Of Health Care Spending Growth
Persists, Projections May Be Off By $770 Billion,” Health Affairs, May 2013)
My take: the health care industry is dynamic and complex. No single factor is the root
cause of spending increases. Understandably, this analysis points too many possibilities
about future costs and lends to development of alternative models and strategies to
contain costs while improving outcomes and safety. It is the 55% that should be better
understood, while the 45% should be validated in continued research.
return to top
Doctors and nurses disagree on their scope of practice, compensation Citation: Donelan, DesRoches, Dittus & Beauhaus, “Perspectives of Physicians and
Nurse Practitioners on Primary Care Practice,” New England Journal of Medicine, May 16,
2013
Objective: to determine opinions about payment parity between physicians and nurses
who provide the same service.
Methodology: “From November 23, 2011, to April 9, 2012, we conducted a national
postal-mail survey of 972 clinicians (505 physicians and 467 nurse practitioners) in
primary care practice. Questionnaire domains included scope of work, practice
characteristics, and attitudes about the effect of expanding the role of nurse practitioners
in primary care. The response rate was 61.2%.”
Conclusions: “Physicians reported working longer hours, seeing more patients, and
earning higher incomes than did nurse practitioners. A total of 80.9% of nurse
practitioners reported working in a practice with a physician, as compared with 41.4% of
physicians who reported working with a nurse practitioner. Nurse practitioners were more
likely than physicians to believe that they should lead medical homes, be allowed hospital
admitting privileges, and be paid equally for the same clinical services. When asked
whether they agreed with the statement that physicians provide a higher-quality
examination and consultation than do nurse practitioners during the same type of primary
care visit, 66.1% of physicians agreed and 75.3% of nurse practitioners
disagreed…Current policy recommendations that are aimed at expanding the supply and
scope of practice of primary care nurse practitioners are controversial. Physicians and
nurse practitioners do not agree about their respective roles in the delivery of primary
care.”
(Source: Donelan, DesRoches, Dittus & Beauhaus, “Perspectives of Physicians and
Nurse Practitioners on Primary Care Practice,” New England Journal of Medicine, May 16,
2013)
My take: there are deep-seated differences in the perspectives of nursing and medical
professions, as reflected in this data. Each considers the other essential, but historically,
physicians have sought to limit the scope of practices of nurses, often resulting in tension
and animosity. Researchers should explore comparative outcomes—safety, outcomes,
and patient experiences in subsequent studies to compare and contrast the two based on
factual data for uncomplicated conditions where both might diagnose and treat. Only then
will the issue be resolved. Survey data will only reinforce the unique and longstanding
perspectives that divide the two.
return to top
Quotable “In the old days, sales representatives from drug companies would chat up local
pharmacists to learn what drugs doctors were prescribing. Now such shoulder-rubbing is
becoming a quaint memory—thanks to vast databases of patient and doctor information
being used by pharmaceutical companies to market drugs…About 31,650 of the nation’s
more than 767,000 practicing physicians, roughly 4 percent, have enrolled in the opt-out program since it was created [in 2006].”—Katie Thomas “A Deep Database on Doctors
Now Guides Drug Company Pitches,” New York Times, May 17, 2013
“The huge differences in list prices have been posted on a government Web site. But for
consumers to compare one hospital with another in a meaningful way, they need to know
a lot more — including the rates that have been negotiated between hospitals and
insurers, the listed prices for outpatient treatments, and the quality of care provided, a
difficult measurement that is in its infancy.”—The Editorial Board, “The Murky World of
Hospital Prices,” New York Times, May 17, 2013
“Releasing prices at hospitals is useful, but why stop there? Patients would also benefit
from more information about prices charged by doctors, prices for common diagnostic
tests, and the prices that insurers negotiate with hospitals, doctors and testing labs. If
nothing else can control health care costs, maybe public embarrassment can.”—The
Editorial Board, “Hospital Pricing Practices gouge Patients: Our View,” USA Today, May
16, 2013
return to top
Fact file Balance of treatment vs. prevention: “in 2012, the segment of global health care
expenditure on treatment was 60%, which will significantly decrease to 35% by
2025…75% of those 60 years of age or older are anticipated to have at least one
chronic condition. By the time this population is 70 years old or more, 50% will
have two or more chronic conditions.” (Source: Frost & Sullivan Research, “Will
Pharma Survive the Headwinds of Change in the New Healthcare Ecosystem”)
Mental health in children: up to one in five children living in the U.S. have mental
disorders, costing $247 billion annually; attention-deficit/hyperactivity disorder, or
ADHD, was the most prevalent diagnosis ( 6.8%); behavioral or conduct problems
(3.5%); anxiety (3%); depression (2.1%); and autism spectrum disorders (1.1%).
About 4.7% of children between the ages of 12 and 17 had an illicit drug-use
disorder in the past year, and 4.2% had an illicit alcohol use disorder. Suicide was
the second leading cause of death among children between 12 and 17 in 2010:
boys have higher rates of suicide while girls are more prone to alcohol abuse and
depression. (Source: CDC, “Mental Health Surveillance Among Children in the
United States, 2005-2011”)
April 2013 health care consumer price index for all urban consumers:
expenditures on medical care services increased 3.4% since April 2012; between
March 2013 and April 2013, expenditures declined 0.1%. Between March 2013 and
April 2013 hospital services dropped 0.7%; inpatient prices dropped 0.9% and
outpatient prices declined by 0.5%. In the past year, expenditures on physician
services climbed 2.7%. By contrast: food expenditures increased 1.5% in the past
year and 0.2% between March 2013 and April 2013. Public transportation
increased 2.6% since in the past year, and decreased 0.4% between March 2013 and April 2013. (Source: Bureau of Labor Statistics, Consumer Price Index based
on revenues from private insurers, privately insured patients and the uninsured)
2013 nursing home, assisted living costs: national median daily cost for a
private room: $230/day, +3.6% over 2012 or $6900/month; median annual rate is
$83,950 vs. $67,525 in 2008. In assisted living, median monthly cost is $3,450, +
4.55% since 2012. (Sources: Genworth Financial; Caitlin Kelly, New York Times,
“Covering the Rising Cost of Long-Term Care,” May 14, 2013)
return to top
Subscribe to the Health Care Reform Memo
Health Care Reform Memo — The weekly Health Care Reform Memo is available for
subscription. Please visit http://www.deloitte.com/centerforhealthsolutions/subscribe. return to top
Deloitte Center for Health Solutions research To learn more about recent Deloitte thought leadership, please visit Deloitte University
Press at www.DUPress.com.
Coming soon: Hospital consolidation: What happens, what’s ahead?
The Affordable Care Act (ACA) of 2010: May 2013 Progress Report
Currently available: Physician adoption of health information technology: Implications for medical
practice leaders and business partners—May 2013. Available online at
www.deloitte.com/us/2013physiciansurveyHIT
Breaking Constraints: Can incentives change consumer health choices?—March
2013. Available online at http://dupress.com/articles/breaking-constraints/?coll=3024
2013 Survey of U.S. Physicians: Physician perspectives about health care reform
and the future of the medical profession—March 2013. Available online at
www.deloitte.com/us/2013physiciansurvey
Health System Chief Information Officers: Juggling responsibilities, managing
expectations, building the future—February 2013. Available online at
www.deloitte.com/us/2013CIOstudy
Unlocking value in health plan M&A: Sometimes the deals don’t deliver—January
2013. Available online at www.deloitte.com/us/2013planconsolidation
Deloitte 2012 Survey of U.S. Health Care Consumers—December 2012. Access a
library of resources including an INFOBrief series, an infographic, and a Five-Year Look Back report. Available online at www.deloitte.com/us/consumerstudies
return to top
Read the blog
To stay up-to-date, check out the Center for Health Solutions’ blog:
A view from the Center—where policy, innovation, and industry meet
http://blogs.deloitte.com/centerforhealthsolutions/
return to top
Upcoming life sciences and health care Dbrief webcasts Anticipating tomorrow's complex issues and new strategies is a challenge. Stay fresh with
Dbriefs – live webcasts that give you valuable insights on important developments
affecting your business.
June 18: Opportunities and Challenges in mHealth. To register, click here.
return to top
Deloitte contacts
Paul H. Keckley, Ph.D., Executive Director, Deloitte Center for Health Solutions
(pkeckley@deloitte.com)
Jessica Blume, U.S. Public Sector National Industry Leader, Deloitte LLP
(jblume@deloitte.com)
Bill Copeland, U.S. Life Sciences and Health Care National Industry Leader, Deloitte LLP
(bcopeland@deloitte.com)
Jason Girzadas, National Managing Director, Life Sciences & Health Care, Deloitte
Consulting LLP (jgirzadas@deloitte.com)
Harry Greenspun, M.D., Senior Advisor, Health Care Transformation and Technology,
Deloitte Center for Health Solutions (hgreenspun@deloitte.com)
Mitch Morris, M.D., National Leader, Health Information Technology, Deloitte Consulting
LLP (mitchmorris@deloitte.com)
George Serafin, Managing Director, Health Sciences Governance Regulatory & Risk
Strategies, Deloitte & Touche LLP (gserafin@deloitte.com)
Rick Wald, Director, Human Capital, Deloitte Consulting LLP (rwald@deloitte.com)
To receive email alerts when new research is published by the Deloitte Center for Health
Solutions, please register at www.deloitte.com/centerforhealthsolutions/subscribe.
To access Center research online, please visit www.deloitte.com/centerforhealthsolutions.
To arrange a briefing for your team, contact Jennifer Bohn (jebohn@deloitte.com).
return to top
Deloitte.com | Security | Legal | Privacy
30 Rockefeller Plaza New York, NY 10112-0015 United States
About Deloitte Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see
www.deloitte.com/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.
Disclaimer This publication contains general information only and Deloitte is not, by means of this publication, rendering accounting, business, financial, investment, legal, tax, or other professional advice or services. This publication is not a substitute for such professional advice or services, nor should it be used as a basis for any decision or action that may affect your business. Before making any decision or taking any action that may affect your business, you should consult a qualified professional advisor.
Deloitte shall not be responsible for any loss sustained by any person who relies on this publication.
Copyright © 2013 Deloitte Development LLC. All rights reserved. Member of Deloitte Touche Tohmatsu Limited
To unsubscribe, reply to this message and add “Unsubscribe” in the subject line.
top related